MOVE 10-K & 10-Q changes, risk factors and insider trading
Corvex, Inc. · Nasdaq · Services-Computer Processing & Data Preparation · CIK 1734750 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as the other information in this Annual Report on Form 10-K, including our financial statements and the related notes thereto, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and the information contained under the heading “Cautionary Note Regarding Forward-Looking Statements” before deciding whether to invest in our common stock.”
New heading “The financial information presented in this “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context, unless specified otherwise. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”
New heading “The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations and growth prospects. In such an event, the market price of our common stock could decline and you may lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. We may update these risk factors in our periodic and other filings with the SEC.”
New heading “Risks Related to the Combined Company Following the Merger with Predecessor Movano”
New heading “The market price of our common stock after the merger may be affected by factors different from those that historically affected the market price of our common stock.”
New heading “Our business relationships may be subject to disruption due to uncertainty associated with the merger.”
New heading “We may fail to realize the anticipated benefits of the Merger.”
New heading “If the Merger does not qualify as a “reorganization” under Section 368(a) of the Code, stockholders of Corvex common stock may be required to recognize gain or loss for U.S. federal income tax purposes upon the exchange of Corvex common stock for our Common Stock in the Merger.”
New heading “Potential litigation against the Company could result in substantial costs and divert management’s attention.”
New heading “The expected dilution caused by the issuance of our securities in connection with the Merger may adversely affect the market price of our Common Stock.”
New heading “Pursuant to the terms of the Merger Agreement, we are required to obtain stockholder approval for conversion of all outstanding shares of our Series C and Series D Preferred Stock into shares of our common stock. We cannot guarantee that our stockholders will approve this matter.”
New heading “Our recent growth may not be indicative of our future growth, and if we do not effectively manage our future growth, our business, operating results, financial condition, and prospects may be adversely affected.”
New heading “We have a limited number of suppliers for significant components of the equipment it uses to build and operate our platform and provide our solutions and services. Any disruption in the availability of these components could delay our ability to expand or increase the capacity of our infrastructure or replace defective equipment.”
New heading “Our business would be harmed if we are not able to access sufficient power or by increased costs to procure power, prolonged power outages, shortages, or capacity constraints.”
New heading “If our data center providers fail to meet the requirements of our business, or if the data center facilities experience damage, interruption, or a security breach, our ability to provide access to our infrastructure and maintain the performance of our network could be negatively impacted.”
New heading “A substantial portion of our revenue is driven by a limited number of our customers, and the loss of, or a significant reduction in, spend from one or a few of our top customers would adversely affect our business, operating results, financial condition, and prospects.”
New heading “If we fail to efficiently enhance our platform and develop and sell new solutions and services and respond effectively to rapidly changing technology, evolving industry standards, changing regulations, and changing customer needs, requirements, or preferences, our platform may become less competitive.”
New heading “The broader adoption, use, and commercialization of AI technology, and the continued rapid pace of developments in the AI field, are inherently uncertain. Failure by our customers to continue to use our platform to support AI use cases in their systems, or our ability to keep up with evolving AI technology requirements and regulatory frameworks, could have a material adverse effect on our business, operating results, financial condition, and prospects.”
New heading “Our operations require substantial capital expenditures, and we will require additional capital to fund our business and support our growth, and any inability to generate or obtain such capital on acceptable terms, if at all, or to lower our total cost of capital, may adversely affect our business, operating results, financial condition, and prospects.”
New heading “Certain of our lease agreements require a pledge of our property and equipment as collateral, which may result in the lessors taking possession of such collateral in the event of a payment default.”
New heading “Our operating results may fluctuate significantly, which could make our future results difficult to predict and could cause our operating results to fall below expectations.”
New heading “We face intense competition and could lose market share to our competitors, which would adversely affect our business, operating results, financial condition, and prospects.”
New heading “A network or data security incident against us, or our third-party providers, whether actual, alleged, or perceived, could harm our reputation, create liability and regulatory exposure, and adversely impact our business, operating results, financial condition, and prospects.”
New heading “We have a history of generating net losses as a result of the substantial investments we have made to grow our business and develop our platform, anticipate increases in our operating expenses in the future, and may not achieve or, if achieved, sustain profitability. If we cannot achieve and, if achieved, sustain profitability, our business, operating results, financial condition, and prospects will be adversely affected.”
New heading “We make substantial investments in our technology and infrastructure, and unsuccessful investments could materially adversely affect our business, operating results, financial condition, and prospects.”
New heading “Our platform is complex and performance problems, defects or vulnerabilities associated with our platform may adversely affect our business, operating results, financial condition, and prospects.”
New heading “Any failure of our IT systems or those of one or more of our IT service providers, business partners, vendors, suppliers, or other third-party service providers, or any other failure by such third parties to provide services to us may negatively impact our relationships with customers and harm our business.”
New heading “Corvex has a limited operating history, which makes it difficult to evaluate our current business and prospects and increases the risks associated with investment in our common stock.”
New heading “If we are unable to attract new customers, retain existing customers, and/or expand sales of our platform, solutions, and services to such customers, we may not achieve the growth we expect, which would adversely affect our business, operating results, financial condition, and prospects.”
New heading “If we are unable to successfully build, expand, and deploy our sales organization in a timely manner, or at all, or to successfully hire, retain, train, and motivate our sales personnel, our growth and long-term success could be adversely impacted.”
New heading “If we do not or cannot maintain the compatibility of our platform with our customers’ existing technology, including third-party technologies that our customers use in their businesses, our business may be adversely affected.”
New heading “As we expand our customer base, we may become further subject to counterparty credit risk, which would adversely impact our business, operating results, financial condition, and prospects.”
New heading “Our long-term success may in part depend on our ability to expand the sale of our platform to customers located outside of the United States, and such international operations would expose it to risks that could have a material adverse effect on our business, operating results, financial condition, and prospects.”
New heading “Our sales cycles can be long and unpredictable, and our sales efforts require considerable time and expense.”
New heading “The sales prices of our offerings may decrease, which may reduce our margins and adversely affect our business, operating results, financial condition, and prospects.”
New heading “Our estimates of market opportunity and forecasts of market growth may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, our business could fail to grow at similar rates, if at all.”
New heading “We may in the future enter into collaborations or strategic alliances with third parties. If we are unsuccessful in establishing or maintaining strategic relationships with these third parties or if these third parties fail to deliver certain operational services, our business, operating results, financial condition, and prospects could be adversely affected.”
New heading “Potential future joint ventures, acquisitions, strategic investments, partnerships, or alliances may not achieve their intended benefits, may be difficult and costly to execute or integrate, may expose us to additional risks and liabilities (including non-controlling interests and shared decision-making), and could adversely affect our business, operating results, financial condition, and prospects.”
New heading “Future acquisitions could include real property and subject us to the general risks associated with the ownership of real property.”
New heading “If negative publicity arises with respect to us, our employees, our third-party suppliers, service providers, or our partners, our business, operating results, financial condition, and prospects could be adversely affected, regardless of whether the negative publicity is true.”
New heading “Our ability to maintain customer satisfaction depends in part on the quality of our customer support and cloud operations services. Our failure to maintain high-quality customer support and cloud operations services could have an adverse effect on our business, operating results, financial condition, and prospects.”
New heading “We rely on our management team and other key employees and will need additional personnel to grow our business, and the loss of one or more key employees or our inability to attract and retain qualified personnel, including members of our board of directors, could harm our business.”
New heading “We believe that our corporate culture has contributed to our success, and if we cannot maintain this culture as we grow, we could lose the innovation, creativity, and teamwork fostered by our culture, and our business may be harmed.”
New heading “Risks Related to Our Healthcare Business”
New heading “Our healthcare business has a limited history of generating revenue, have a history of operating losses, and we may never achieve or maintain profitability.”
New heading “Failure to obtain, maintain, protect, or enforce our intellectual property and proprietary rights could enable others to copy or use aspects of our platform without compensating it, which could harm our brand, business, operating results, financial condition, and prospects.”
New heading “Third parties may claim that our platform infringes, misappropriates, or otherwise violates our intellectual property rights, and such claims could be time-consuming or costly to defend or settle, result in the loss of significant rights, or harm our relationships with our customers or reputation in the industry.”
New heading “We license technology from third parties for the development of our solutions, and our inability to maintain those licenses could harm our business.”
New heading “Some of our technology incorporates “open-source” software, and failure to comply with the terms of the underlying open-source software licenses could adversely affect our business, results of operations, financial condition, and prospects.”
New heading “Risks Related to Legal Matters and Regulation”
New heading “We are subject to laws and regulations, including governmental export and import controls, sanctions, and anti-corruption laws, that could impair our ability to compete in our markets and subject it to liability if we are not in full compliance with applicable laws.”
New heading “Our customer and counterparty diligence obligations may increase, and any failure to implement and maintain effective know-your-customer, anti-money laundering and sanctions compliance controls could adversely affect us.”
New heading “We are subject to laws, regulations, and industry requirements related to data privacy, data protection and information security across different markets where it conducts our business and such laws, regulations, and industry requirements are constantly evolving and changing. Any actual or perceived failure to comply with such laws, regulations, and industry requirements, or our privacy policies, could harm our business.”
New heading “Our business is subject to a wide range of laws and regulations, and our failure to comply with those laws and regulations could harm our business.”
New heading “Our Medical Ring is subject to ongoing regulatory obligations and review and failure to comply with applicable regulatory requirements may adversely affect our business and operations.”
New heading “We may become involved in litigation that may adversely affect us.”
New heading “We have identified material weaknesses in our internal control over financial reporting. If our remediation of such material weaknesses is not effective, or if we experience additional material weaknesses in the future or otherwise fail to develop and maintain effective internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired.”
New heading “We incur significant costs and management resources as a result of operating as a public company.”
New heading “We could be subject to additional tax liabilities and United States federal and global income tax reform could adversely affect it.”
New heading “Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited.”
New heading “We could be required to collect additional sales, use, value added, digital services, or other similar taxes or be subject to other liabilities with respect to past or future sales, that may increase the costs our customers would have to pay for our solutions and adversely affect our business, operating results, financial condition, and prospects.”
New heading “If our estimates or judgments relating to our critical accounting policies prove to be incorrect or financial reporting standards or interpretations change, our operating results could be adversely affected.”
New heading “We are exposed to fluctuations in currency exchange rates, which could negatively affect our business, operating results, financial condition, and prospects.”
New heading “Risks Related to the Company Generally”
New heading “Adverse global macroeconomic conditions, geopolitical risks, or reduced spending on AI and machine learning or on cloud infrastructure could adversely affect our business, operating results, financial condition, and prospects.”
New heading “We may be adversely affected by natural disasters, pandemics, and other catastrophic events, and by man-made problems such as war and regional geopolitical conflicts around the world, that could disrupt our business operations, and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.”
New heading “Environmental, social, and governance factors may impose additional costs and expose us to new risks.”
New heading “The level of insurance coverage that we purchase may prove to be inadequate, which could materially and adversely impact our business, financial condition, and results of operations.”
New heading “Risks Related to Ownership of Our Common Stock”
New heading “The market price of our common stock may be volatile, and you could lose all or part of your investment.”
New heading “Sales of substantial amounts of our common stock in the public markets, or the perception that they might occur, could cause the market price of our common stock to decline.”
New heading “If financial analysts issue inaccurate or unfavorable research regarding, or do not or cease to cover, our common stock, our stock price and trading volume could decline.”
New heading “Our amended and restated certificate of incorporation contains exclusive forum provisions for certain claims, which may limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.”
New heading “We could be subject to securities class action litigation.”
New heading “Provisions in our charter documents and under Delaware law could make an acquisition of our company, which may be beneficial to our stockholders, more difficult and may limit attempts by our stockholders to replace or remove our current management and members of our board of directors.”
New heading “Holders of the Series A and Series B Preferred Stock have certain voting and other rights that may adversely affect holders of our common stock, and the holders of the Preferred Stock may have different interests from and vote their shares in a manner deemed adverse to, holders of our common stock.”
Removed heading “Risks Related to Our Business”
Removed heading “Risks Related to Product Development, Manufacturing and Commercialization”
Removed heading “Risks Related to Intellectual Property and Other Legal Matters”
Removed heading “Risks Related to Regulation”
Removed heading “Risks Related to Owning Our Securities and Our Financial Results”
Removed heading “We are an early-stage technology company with a limited history of generating revenue, have a history of operating losses, and we may never achieve or maintain profitability.”
Removed heading “We may be unable to continue as a going concern if we do not successfully raise additional capital on favorable terms, or at all, or if we fail to generate sufficient revenue from operations.”
Removed heading “Our efforts may never demonstrate the feasibility of our proposed CGM and blood pressure monitoring solution.”
Removed heading “If we are not successful in attracting and retaining highly qualified personnel, we may not be able to successfully implement our business strategy.”
Removed heading “We will need to grow the size of our organization, and we may experience difficulties in managing this growth.”
Removed heading “We may acquire businesses or products, or form strategic alliances, in the future, and we may not realize the benefits of such acquisitions.”
Removed heading “The sizes of the markets for our current and future products have not been established with precision and may be smaller than we estimate.”
Removed heading “Our business could be negatively impacted by corporate social responsibility and sustainability matters.”
Removed heading “Risks Related to Product Development, Manufacturing and Commercialization”
Removed heading “We are highly dependent on the success of our initial products, the Evie Ring and the EvieMED Ring, and cannot give any assurance that they will be successfully commercialized.”
Removed heading “If we do not successfully manage the launch and marketing of new products or services, our financial results could be adversely affected.”
Removed heading “The use of artificial intelligence presents new risks and challenges to our business.”
Removed heading “It is difficult and costly to protect our intellectual property and our proprietary technologies, and we may not be able to ensure their protection.”
Removed heading “If we are unable to protect the confidentiality of our proprietary information and know-how, the value of our technology and products could be adversely affected.”
Removed heading “We may in the future be a party to intellectual property litigation or administrative proceedings that could be costly and could interfere with our ability to develop our products.”
Removed heading “We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of their former employers or other third parties or claims asserting ownership of what we regard as our own intellectual property.”
Removed heading “Increased use of social media could create or amplify the effects of negative publicity and adversely affect sales and operating results.”
Removed heading “Risks Related to Regulation”
Removed heading “We expect to seek FDA clearance with respect to additional EvieMED Ring monitoring capabilities and expect to seek FDA clearance or approval for our planned CGM and blood pressure monitoring solution, which may be difficult to achieve, and existing laws or regulations or future legislative or regulatory changes may affect our business.”
Removed heading “Our current or future products may be subject to product recalls that could harm our reputation.”
Removed heading “Failure to comply with privacy and security laws and regulations could result in fines, penalties and damage to our reputation and have a material adverse effect on our business.”
Removed heading “Our stock price has fluctuated widely and is likely to continue to be volatile.”
Removed heading “Our Certificate of Incorporation designates specific courts as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us.”
Removed heading “We are incurring significant costs as a public company that reports to the SEC and our management is required to devote substantial time to meet compliance obligations.”
Removed heading “Our charter documents and Delaware law may inhibit a takeover that stockholders consider favorable.”
Largest changes
“Our business depends on the overall demand for and adoption of AI and machine learning and cloud infrastructure and on the economic health of our current and prospective customers. In addition, the purchase of our platform is often discretionary and may involve a significant commitment of capital and other resources. …”see in full comparison
“As many of these factors are beyond our control, it is difficult for us to accurately forecast our future operating results. If the assumptions that we use to plan our business are incorrect or change in reaction to changes in our market, we may be unable to maintain consistent revenue or revenue growth, the value of our stock could be volatile, and it may be difficult to achieve and, if achieved, maintain profitability. …”see in full comparison
“Further, the current global macroeconomic environment could make it more difficult to raise additional capital on favorable terms, if at all. Such terms may involve restrictive covenants making it difficult to engage in capital raising activities and pursue business opportunities, including potential acquisitions. …”see in full comparison
“In certain foreign jurisdictions, these regulatory requirements may be more stringent than those in the United States. These laws and regulations are subject to change over time and thus we must continue to monitor and dedicate resources to ensure continued compliance. In particular, the global AI regulatory environment continues to evolve as regulators and lawmakers have started proposing and adopting, or are currently considering, regulations and guidance specifically on the use of AI. …”see in full comparison
“There is a risk that as we expand, we may assume liabilities for breaches experienced by the companies we acquire. Additionally, there are potentially inconsistent world-wide government regulations pertaining to data protection and privacy. Despite our efforts to comply with applicable laws, regulations and other obligations relating to privacy, data protection, and information security, it is possible that our practices, offerings, or platform could fail, or be alleged to fail to meet applicable requirements. …”see in full comparison
“From time to time, we may be subject to claims, suits, and other proceedings. Regardless of the outcome, legal proceedings can have an adverse impact on us because of legal costs and diversion of management attention and resources, and could cause us to incur significant expenses or liability, adversely affect our brand recognition, or require us to change our business practices. …”see in full comparison
Full comparison: every changed paragraph (354)
Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as the other information in this Annual Report on Form 10-K, including our financial statements and the related notes thereto, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and the information contained under the heading “Cautionary Note Regarding Forward-Looking Statements” before deciding whether to invest in our common stock.
The financial information presented in this “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context, unless specified otherwise. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.
The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations and growth prospects. In such an event, the market price of our common stock could decline and you may lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. We may update these risk factors in our periodic and other filings with the SEC.
Risks Related to Our Business
Risks Related to Product Development, Manufacturing
and Commercialization
Risks Related to Intellectual Property and
Other Legal Matters
Risks Related to Regulation
Risks Related to Owning Our Securities and
Our Financial Results
Risks Related to the Combined Company Following the Merger with Predecessor Movano
The market price of our common stock after the merger may be affected by factors different from those that historically affected the market price of our common stock.
The businesses of our Corvex division differs from those of our Movano division in important respects, and, accordingly, the results of operations of Corvex after the merger, as well as the market price of our common stock, may be affected by factors different from those that historically affected the results of operations of the Company. For further information on the respective businesses of each of our divisions and certain factors to consider in connection with those businesses, see the section titled “Item 1 Business” above and “Risk Factors-Risks related to Corvex” below. Additionally, the market price of our common stock may fluctuate significantly following the merger. Moreover, general fluctuations in stock markets could have a material adverse effect on the market for, or liquidity of, the common stock of the combined company, regardless of our actual operating performance.
Our business relationships may be subject to disruption due to uncertainty associated with the merger.
Parties with which we do business may experience uncertainty associated with the merger, including with respect to current or future business relationships with the Company. Our business relationships may be subject to disruption as parties with which the Company does business may attempt to negotiate changes in existing business relationships or consider entering into business relationships with parties other than the Company. These disruptions could have an adverse effect on the businesses, financial condition, results of operations or prospects of the Company, including an adverse effect on our ability to realize the anticipated benefits of the merger.
We may fail to realize the anticipated benefits of the Merger.
The Company believes that there are significant benefits that may be realized by the Merger. However, the efforts to realize these benefits will be a complex process and may disrupt our existing operations if not implemented in a timely and efficient manner. The full benefits of the Merger may not be realized as expected or may not be achieved within the anticipated time frame, or at all. Failure to achieve the anticipated benefits of the Merger could adversely affect our business, operating results or financial condition and cause the combined business to not perform as expected.
Our Corvex and Movano divisions have operated independently before the completion of the Merger and there can be no assurances that the integration of the Corvex division into the Company can be achieved successfully. Specifically, the following issues, among others, must be addressed to realize the anticipated benefits of the Merger:
If the Merger does not qualify as a “reorganization” under Section 368(a) of the Code, stockholders of Corvex common stock may be required to recognize gain or loss for U.S. federal income tax purposes upon the exchange of Corvex common stock for our Common Stock in the Merger.
The Company intends for the Merger to qualify as a “reorganization” within the meaning of Section 368(a) of the Code for U.S. federal income tax purposes. The completion of the Merger is not conditioned on the Merger qualifying for the intended tax treatment or upon the receipt of an opinion of counsel to that effect, and the Company has not requested a ruling from the IRS regarding the U.S. federal income tax consequences of the Merger.
If the Merger does not qualify as a “reorganization” within the meaning of Section 368(a) of the Code, a Corvex stockholder that is a U.S. holder generally would recognize a gain or loss for U.S. federal income tax purposes upon the exchange of the legacy Corvex common stock and series seed preferred stock for our Common Stock in the Merger.
Potential litigation against the Company could result in substantial costs and divert management’s attention.
Securities class action lawsuits and derivative lawsuits are often brought against public companies in connection with merger transactions. Even if such lawsuits are unsuccessful, defending against them can result in substantial costs and divert management’s attention.
Stockholders of the Company may file lawsuits against the Company and/or the directors and officers of the Company in connection with the Merger. Potential lawsuits could result in significant costs to the Company, including any costs associated with the indemnification of directors and officers. There can be no assurance that any of the defendants will be successful in the outcome of any potential lawsuits.
The expected dilution caused by the issuance of our securities in connection with the Merger may adversely affect the market price of our Common Stock.
The expected dilution caused by the issuance of the new shares of our Common Stock in connection with the conversion of the convertible preferred stock issued to legacy Corvex stockholders in connection with the payment of the merger consideration upon the closing of the Merger and the assumption of Corvex equity awards and the issuance of new equity awards in connection with the Merger, either alone or in combination with any negative impact on the market price of our Common Stock following the release of lock-up restrictions entered by the respective directors, officers and certain stockholders of legacy Corvex and the Company in connection with the Merger, may result in fluctuations in the market price of our Common Stock, including a stock price decrease.
Pursuant to the terms of the Merger Agreement, we are required to obtain stockholder approval for conversion of all outstanding shares of our Series C and Series D Preferred Stock into shares of our common stock. We cannot guarantee that our stockholders will approve this matter.
Under the terms of the Merger Agreement, we agreed to take all action necessary under applicable law to obtain the requisite approval for the conversion of all outstanding shares of Series C Preferred Stock and Series D Preferred Stock issued in the Merger into shares of our common stock, as required by the Nasdaq Listing Rules, at a stockholders meeting to be held as soon as practicable following the execution of the Merger Agreement, which would be time consuming and costly. The conversion of all such Series C Preferred Stock and Series D Preferred Stock will cause the issuance of a maximum of 53,778,572 shares of our Common Stock, resulting in dilution to existing holders of our Common Stock and increase the number of shares eligible for resale in the public market. We have a contractual obligation under the Merger Agreement to register such shares of Common Stock for resale shortly following their conversion if approved by our stockholders at the stockholders meeting.
Risks
Related to Ourour AI Cloud Computing Business and Industry
Our recent growth may not be indicative of our future growth, and if we do not effectively manage our future growth, our business, operating results, financial condition, and prospects may be adversely affected.
Our AI cloud computing business was founded in October 2024, launched our platform in the first quarter of 2025 and generated revenue of $4.9 million for the nine months ended September 30, 2025. Investors should not rely on the revenue growth of any prior period as an indication of our future performance. Even if our revenue continues to increase, our revenue growth rate may decline in the future as a result of a variety of factors. Overall growth of our revenue will depend on a number of factors, including but not limited to our ability to:
In addition to the factors discussed above, our revenue growth may also be impacted by industry-specific factors, particularly the continued development of AI (including advancements in AI technology that may lead to further compute efficiencies), the broader adoption, use, and commercialization of AI and any impacts of the developing AI regulatory environment.
As many of these factors are beyond our control, it is difficult for us to accurately forecast our future operating results. If the assumptions that we use to plan our business are incorrect or change in reaction to changes in our market, we may be unable to maintain consistent revenue or revenue growth, the value of our stock could be volatile, and it may be difficult to achieve and, if achieved, maintain profitability. In addition, changes in the macroeconomic environment, including actual or perceived global banking and finance related issues, domestic and foreign regulatory uncertainty, changes in trade policies (including the imposition of tariffs, trade controls and other trade barriers), labor shortages, supply chain disruptions, volatile interest rates and inflation, spending environments, geopolitical instability, warfare and uncertainty, including the effects of the conflicts in the Middle East and Russia/Ukraine and tensions between China and Taiwan, weak economic conditions in certain regions, or a reduction in AI spending regardless of macroeconomic conditions may impact our growth.
In addition, as we have grown, our number of customers has also increased, and we have increasingly managed more complex deployments of our infrastructure in more complex computing environments. The rapid growth and expansion of our business places a significant strain on our management, operational, engineering, and financial resources. To manage any future growth effectively, we must continue to improve and expand our infrastructure, including information technology (“IT”) and financial infrastructure, our operating and administrative systems and controls, and our ability to manage headcount, capital, and processes in an efficient manner. If we do not manage future growth effectively, our business, operating results, financial condition, and prospects would be harmed.
As an early-stage company, our systems, controls, staffing, product capabilities, and other aspects of our operations will need to continue to evolve to support current demand and any future revenue growth. If we continue to experience rapid growth, we may not be able to successfully implement or scale improvements to our systems, processes, and controls in an efficient, timely, or cost-effective manner. As we grow, our existing systems, processes, and controls may not prevent or detect all errors, omissions, or fraud. Any future growth will continue to add complexity to our organization and require effective coordination throughout our organization. Failure to manage any future growth effectively could result in increased costs, cause difficulty or delays in deploying our platform to new and existing customers, reduce demand for our platform, and cause difficulties in introducing new solutions and services or other operational difficulties, and any of these difficulties would adversely affect our business, operating results, financial condition, and prospects.
We have a limited number of suppliers for significant components of the equipment it uses to build and operate our platform and provide our solutions and services. Any disruption in the availability of these components could delay our ability to expand or increase the capacity of our infrastructure or replace defective equipment.
We do not manufacture the components we use to build the technology infrastructure underlying our platform. We have a limited number of suppliers that we use to procure and configure significant components of the technology infrastructure that we use to operate our platform and provide our solutions and services to our customers. Additionally, for the year ended December 31, 2025, three suppliers accounted for 63%, 23%, and 9% of our total purchases. Utilizing a limited number of suppliers of the components for our technology infrastructure exposes us to risks, including:
Our technology infrastructure components suppliers fulfill our supply requirements on the basis of individual purchase orders. We currently have no long-term contracts or arrangements with our suppliers that guarantee capacity or the continuation of any particular payment terms. Accordingly, our suppliers are not obligated to continue to fulfill our supply requirements, and the prices it is charged for our products and, if applicable, services could be increased on short notice. Any delay from our suppliers may result in our inability to provide our infrastructure and platform to our customers on a timely basis and fulfill our contractual requirements under our customer contracts, and we may be unable to obtain replacement parts or warranty service on the timelines required to meet our delivery schedules and service level commitments. Suppliers may also suspend, reduce, or discontinue sales, support, or prioritized allocations to us if we experience adverse brand or reputational issues or any perceived compliance lapses (including with know-your-customer (“KYC”)/anti-money laundering (“AML”), sanctions, or related screening obligations) that cause us to be viewed as a higher-risk counterparty, which could disrupt operations, extend lead times, increase costs, and impair our ability to meet customer commitments. If we are required to change suppliers, our ability to meet our obligations to our customers, including scheduled compute access, could be adversely affected and our solutions may not be as performant, which could cause the loss of sales from existing or potential customers, delayed revenue, or an increase in our costs, which could adversely affect our margins. The process to select and onboard alternate suppliers, including software vendors, may be lengthy, and transitioning suppliers could require installation or engineering work, retraining or other processes that may introduce downtime risk and incremental expense. Any production or shipping interruptions for any reason, such as a natural disaster, epidemics, pandemics, capacity shortages, quality problems, or strike or other labor disruption at one of our supplier locations or at shipping ports or locations, could adversely affect sales of our solution and services offerings.
In addition, we are continually working to expand and enhance our infrastructure features, technology, and network and other technologies to accommodate substantial increases in the computing power required by more compute-intensive workloads on our platform, the amount of data it hosts, and our overall number of total customers. We may be unable to project accurately the rate or timing of these increases or to allocate resources successfully to address such increases and may underestimate the data center capacity needed to address such increases. Our limited number of suppliers, in turn, may not be able to quickly respond to our needs, which would have a negative impact on customer experience and contractual performance. In the future, we may be required to allocate additional resources, including spending substantial amounts, to build, purchase, lease or license data centers and equipment and upgrade our technology and network infrastructure in order to handle increased customer usage, and our suppliers may not be able to satisfy such requirements. There is no assurance that we will be able to enter into agreements to build, purchase, lease or license data centers and related equipment and infrastructure in a timely manner or on terms that are favorable to us. If we are not able to expand our data center capacity to meet the demands of our customers, our business, operating results, financial condition, and prospects may be adversely affected. In addition, our network or our suppliers’ networks might be unable to achieve or maintain data transmission capacity high enough to effectively deliver our services. We may also face constraints on our ability to deliver our platform, solutions, and services if there is limited power supply. Our failure, or our suppliers’ failure, to achieve or maintain high data transmission capacity and sufficient electrical services would impact our ability to meet customer needs and could significantly reduce consumer demand for our services. Such reduced demand and resulting loss of compute, cost increases, or failure to upgrade our equipment or adapt to new technologies would harm our business, operating results, financial condition, and prospects.
Moreover, our suppliers themselves rely on a complex network of third-party suppliers for semiconductor manufacturing, hardware components, and other critical inputs, which introduces additional risks to our supply chain. For example, NVIDIA relies on suppliers such as Taiwan Semiconductor Manufacturing Company for semiconductor fabrication and other manufacturers for compute and networking components. Any disruption in the operations of these upstream suppliers, whether due to equipment failures, geopolitical factors such as the potential for military conflict between China and Taiwan, or supply chain constraints, could affect our suppliers’ ability to supply the significant components of the equipment it uses to operate our platform and provide our solutions and services to our customers, which would, in turn, affect the availability of our solutions and services, as well as lead times.
In addition, to the extent any of our suppliers’ businesses are impacted by business, legal compliance, litigation, and financial concerns, including regulatory scrutiny and export controls, our business, operating results, financial condition, and prospects may be adversely affected. For example, increasing use of tariffs, economic sanctions and export controls has impacted and may in the future impact the availability and cost of GPUs and other components of our platform. Broad-based tariffs imposed on imported goods have increased the cost of, among other goods, semiconductors and GPUs imported into the United States. Escalation of tariffs or other trade restrictions applicable to semiconductors, server hardware, networking equipment, or power infrastructure could increase equipment costs, extend lead times, and reduce availability. Intensifying geopolitical tensions or conflict affecting key technology manufacturing hubs, including potential disruptions impacting the Taiwan semiconductor ecosystem, could materially impair our suppliers’ ability to deliver critical components on required schedules or at expected costs, which could adversely affect our ability to meet customer demand and our operating results. Further, stringent export controls targeting semiconductor manufacturing equipment and other items related to advanced integrated circuits may increase the cost of such equipment or otherwise limit the supply chain. Additional export restrictions imposed on components of our technologies may also provoke responses from foreign governments that negatively impact our supply chain, increase the costs for affected imported goods, or limit our ability to obtain additional hardware components, which would also substantially reduce our ability to provide or develop our platform, solutions, and services.
In the event of a supplier unavailability or discontinuation of services, component shortage, or supply interruption, we may not be able to secure alternate sources in a timely manner. Securing alternate sources of supply for these components or services may be time-consuming, difficult, and costly and we may not be able to source these components or services on terms that are acceptable to it, or at all, which may undermine our ability to fill our orders in a timely manner. Any interruption or delay in the supply of any of these components or services, or the inability to obtain these components or services from alternate sources at acceptable prices and within a reasonable amount of time, would harm our ability to meet the demand of our customers, which in turn would have an adverse effect on our business, operating results, financial condition, and prospects.
Our business would be harmed if we are not able to access sufficient power or by increased costs to procure power, prolonged power outages, shortages, or capacity constraints.
We depend on being able to secure power for our data center facilities, in a cost-effective manner. Our inability to secure sufficient power or any power outages, shortages, supply chain issues, capacity constraints, or significant increases in the cost of securing power could have an adverse effect on our business, operating results, financial condition, and prospects. There can be no assurance that we will be able to secure sufficient, cost-effective electrical power and suitable data center space on acceptable terms, or at all.
We rely on third parties to provide a sufficient amount of power to maintain our leased or licensed data center facilities and meet the needs of our current and future customers. We may experience insufficient power to operate our cloud service. Any limitation on the delivered energy supply would limit our ability to operate our platform. These limitations would have a negative impact on a given data center or limit our ability to grow our business which could negatively affect our business, operating results, financial condition, and prospects. Limitations on generation, transmission, and distribution may also limit our ability to obtain sufficient power capacity for potential expansion sites in new or existing markets. Power providers, other participants in the power market, and those entities that regulate us may impose onerous operating conditions to any approval or provision of power or we may experience significant delays and substantial increased costs to provide the level of electrical service required by our current or future leased or licensed data centers, or any data centers it may choose to construct in the future. Our ability to find appropriate sites for expansion, including existing sites to lease or license, will also be limited by access to power.
Our data center facilities are affected by problems accessing electricity sources, such as planned or unplanned power outages and limitations on transmission or distribution of power. Unplanned power outages, including, but not limited to those relating to large storms, earthquakes, fires, tsunamis, cyberattacks, physical attacks on utility infrastructure, war, and any failures of electrical power grids more generally, and planned power outages by public utilities could harm our customers and our business. Further, we may not control access to building infrastructure such as generators or fuel tanks at any leased data center facilities As a result, in the event of a power outage, we could be dependent upon the landlord, as well as the utility company, to restore the power. Even if we attempt to limit our exposure to system downtime by using backup generators, which are in turn supported by onsite fuel storage and through contracts with fuel suppliers, these measures may not always prevent downtime or solve for long-term or large-scale outages. Any outage or supply disruption could adversely affect our customer experience, as well as our business, operating results, financial condition, and prospects.
The global energy market is currently experiencing inflation and volatility pressures. Various macroeconomic and geopolitical factors are contributing to the instability and global power shortage, including the war in Russia/Ukraine, severe weather events, governmental regulations, government relations, and inflation. We expect the cost for power to continue to be volatile and unpredictable and subject to inflationary pressures, which could materially affect our financial forecasting, business, operating results, financial condition, and prospects.
If our data center providers fail to meet the requirements of our business, or if the data center facilities experience damage, interruption, or a security breach, our ability to provide access to our infrastructure and maintain the performance of our network could be negatively impacted.
We lease space in or otherwise license use of third-party data centers located in the United States. Our business is reliant on these data center facilities. Given that we lease or license use of this data center space, we do not control the operation of these third-party facilities. Consequently, we could be subject to service disruptions as well as failures to provide adequate support for reasons that are outside of our direct control. Our data center facilities and network infrastructure are vulnerable to damage or interruption from a variety of sources including earthquakes, floods, fires, power loss, system failures, computer and other cybersecurity vulnerabilities, physical or electronic break-ins, human error, malfeasance or interference, including by employees, former employees, or contractors, as well as terrorist acts and other catastrophic events. We and the data center facilities we lease space in or license use of have experienced, and may in the future experience, disruptions, outages, and other performance problems due to a variety of factors, including availability or sufficiency of power, infrastructure changes, and capacity constraints, occasionally due to an overwhelming number of customers accessing our infrastructure simultaneously. Our third-party data centers and network infrastructure may also be subject to cybersecurity attacks, including supply chain attacks, due to the actions of outside parties or human error, malfeasance, insider threats, system errors or vulnerabilities, insufficient cybersecurity controls, a combination of these, or otherwise, which may cause service outages and otherwise impact our ability to provide our solutions and services. We likewise depends on software and hardware performing in accordance with manufacturers’ and vendors’ specifications; however, warranties, support and updates or patches may be insufficient, unavailable or delayed. While we take steps to review the security measures of our third-party data centers, we cannot ensure that the measures in place will be sufficient to prevent a cybersecurity attack or to protect the continued operation of our platform in the event of a cybersecurity attack, and any impact to our solutions and services may also impact our business, operating results, financial condition, and prospects. Data center facilities housing our network infrastructure may also be subject to local administrative actions, changes to legal or permitting requirements, labor disputes, litigation to stop, limit, or delay operations, and other legal challenges, including local government agencies seeking to gain access to customer accounts for law enforcement or other reasons. In addition, while we have entered into various agreements for the lease of data center space, equipment, maintenance, and other services, those third parties could fail to deliver on their contractual obligations under those agreements, including agreements to provide certain data, equipment, and utilities information required to run our business. Furthermore, we may require the data centers we lease to have certain highly specific attributes in order to effectively run our business. For example, our data centers may also require networking equipment, high-speed interconnects, enhanced access to power, and liquid cooling infrastructure. In some cases, these third-party data centers are required to undergo extensive retrofitting and improvement efforts, including to incorporate novel developments in our industry, which are time consuming, expensive, and less efficient than if it were to lease from spaces already designed for our operations, and which may not ultimately be successful in meeting all of our requirements.
If third parties fail to successfully deliver on such performance requirements, our ability to maintain the performance of our network would be negatively impacted. Similarly, failures, defects, or delays in our own software or in open-source or commercially licensed software it uses can impair availability, functionality, or security and could result in service credits, liquidated damages, or termination rights under our customer contracts.
Other factors, many of which are beyond our control, that can affect the delivery, performance, and availability of our platform include:
If we do not accurately anticipate the data center capacity required by our customers, including if they use less or more of our infrastructure than expected, we would incur additional costs due to leasing more capacity than is used and paid for by our customers or, alternatively, in seeking additional data center capacity to fulfill unexpected demand on terms that may not be economically reasonable or acceptable to us, if we are able to lease additional capacity at all. We may also need to seek additional data center capacity in the event any leases with third parties are terminated or not renewed, which we may be unable to do on reasonable terms or at all. Moreover, to the extent we build or otherwise secure additional capacity (including through owned or build-to-suit data centers) and customer demand is insufficient to utilize such capacity at anticipated levels, we may not realize expected returns on these investments, and our business, operating results, financial condition, and prospects would be adversely affected.
The occurrence of any of these factors, or our inability to efficiently and cost-effectively fix such errors or other problems that may be identified, could damage our reputation, negatively impact our relationship with our customers, or otherwise materially harm our business, operating results, financial condition, and prospects.
In the future, we may develop our own data centers, rather than relying on third parties and, because of our limited experience in this area, it could experience unforeseen difficulties. For example, any potential expansion of our data center infrastructure would be complex, and unanticipated delays in the completion of those projects or availability of components may lead to increased project costs, operational inefficiencies, or interruptions in the delivery or degradation of the quality of our platform. In addition, there may be issues related to this infrastructure that are not identified during the testing phases of design and implementation, which may only become evident after we have started to fully utilize the underlying equipment, that could further degrade our platform or increase our costs. Construction and delivery of new or expanded facilities also present additional risks, including project delays; unexpected budget changes and cost overruns; increased prices for, or shortages of, building supplies, raw materials, and data center equipment; labor availability issues, including as a result of unionization, labor negotiations or labor disputes, or work stoppages among contractors and subcontractors; environmental issues and geologic conditions; and delays or conditions imposed in connection with permits and other approvals from public agencies, utilities, or other organizations. Prices for key inputs required for new builds and expansions — including data center space, construction labor and materials, electrical and cooling infrastructure, networking, and GPUs — may be volatile and may increase materially between project underwriting and delivery, which could delay projects, increase capital intensity, compress returns, or render certain builds uneconomic. Any of these issues could delay readiness, increase capital intensity, limit capacity additions, or impair expected performance.
A substantial portion of our revenue is driven by a limited number of our customers, and the loss of, or a significant reduction in, spend from one or a few of our top customers would adversely affect our business, operating results, financial condition, and prospects.
A substantial portion of our revenue is driven by a limited number of customers.
For the year ended December 31, 2025, three customers accounted for approximately 32%, 19%, and 16%, respectively, of our unaudited revenue. None of our other customers represented 10% or more of our revenue for the year ended December 31, 2025. Any negative changes in demand from our top customers, in our top customers’ ability or willingness to perform under their contracts with us or in our broader strategic relationship with our top customers would adversely affect our business, operating results, financial condition, and prospects. In addition to risks associated with customers discontinuing use of our solutions, we face risks that customers may fail to continue usage following renewal events, or even during the term of a lease. We offer varying lease lengths and therefore faces renewal timing risk and credit-quality risk from our counterparties. Where contractual offtake periods are shorter than associated lease obligations, we bear the risk that renewal will occur at lower prices or not at all, requiring rapid replacement of non-performing or non-renewing customers and potentially resulting in periods of under-utilized capacity and lower cash flows. Additionally, we may experience contractual non-performance by certain customers, which may result in losses.
We anticipate that we will continue to derive a significant portion of our revenue from a limited number of customers for the foreseeable future, and in some cases, the portion of our revenue attributable to certain customers may increase in the future. The composition of our customer base, including our top customers, may fluctuate from period to period given that our customer composition has evolved and is expected to continue to evolve significantly as our business continues to evolve and scale and as the use cases for AI continue to develop. However, we may not be able to maintain or increase revenue from our top customers for a variety of reasons, including the following:
Customer relationships often require us to continually improve our platform, which may involve significant technological and design challenges, and our customers may place considerable pressure on it to meet tight development and capacity availability schedules. Accordingly, we may have to devote a substantial amount of our resources to our strategic relationships, which could detract from or delay our completion of other important development projects. Delays in making capacity or AI infrastructure available and performing to contractual specifications could impair our relationships with our customers and negatively impact forecasted sales of the services under development. Customer dissatisfaction with our products and services may materially and adversely affect our business, and a failure to continuously improve our solutions may render our technology obsolete.
If we fail to efficiently enhance our platform and develop and sell new solutions and services and respond effectively to rapidly changing technology, evolving industry standards, changing regulations, and changing customer needs, requirements, or preferences, our platform may become less competitive.
The market in which we compete is relatively new and subject to rapid technological change, evolving industry standards and regulatory changes, as well as changing customer needs, requirements, and preferences. The success of our business will depend, in part, on our ability to, predict, adapt, and respond effectively to these changes on a timely basis. If we are unable to develop and sell new solutions and services that satisfy and are adopted by new and existing customers and provide enhancements, new features, and capabilities to our infrastructure that keep pace with rapid technological and industry change, our business, operating results, financial condition, and prospects could be adversely affected. Further, prospective or existing customers may influence our product roadmap by requiring features optimal for their particular use case. If we are unable to adapt to meet customers’ requirements, they may use competitive offerings or internal solutions that eliminate reliance on third-party providers, and our business, operating results, financial condition, and prospects could be adversely affected. Moreover, prioritizing development of such features may require significant engineering resources and may not be compatible with the requirements of other customers, which could impact overall adoption of our platform. If new technologies emerge that limit or eliminate reliance on AI cloud platform providers like us, or that enable our competitors to deliver competitive services at lower prices, more efficiently, more conveniently, or more securely, such technologies could adversely impact our ability to compete. If our solutions do not allow it or our customers to comply with the latest regulatory requirements, sales of our platform, solutions, and services to existing customers may decrease and new customers will be less likely to adopt our platform.
Our future growth is dependent upon our ability to continue to meet the needs of new customers and the expanding needs of our existing customers as their use of our platform, solutions, and services grows. As sales of our platform grow, we will need to devote additional resources to expanding, improving, and maintaining our infrastructure and integrating with third-party applications. In addition, we will need to appropriately scale our internal business systems and our services organization, including customer support, to serve our growing customer base, and to improve our IT and financial infrastructure, operating and administrative systems, and our ability to effectively manage headcount, capital and processes, including by reducing costs and inefficiencies. Any failure of, or delay in, these efforts could result in impaired system performance and reduced customer satisfaction, which would negatively impact our revenue growth and our reputation and could cause existing customers to reduce or terminate use of our platform. We may not be successful in developing or implementing these technologies. In addition, it takes a significant amount of time to plan, develop and test improvements to our technologies and infrastructure, and it may not be able to accurately forecast demand or predict the results it will realize from such improvements. In some circumstances, we may also determine to scale our technology through the acquisition of complementary businesses and technologies rather than through internal development, which may divert management’s time and resources. To the extent that we do not effectively scale our operations to meet the needs of our growing customer base and to maintain performance as our customers expand their use of our services, we will not be able to grow as quickly as it anticipates, our customers may reduce or terminate use of our platform and it will be unable to compete as effectively and our business, operating results, financial condition, and prospects will be adversely affected.
Management's Discussion & Analysis (MD&A)
New heading “Recent Developments”
New heading “AI Cloud Computing Business”
New heading “Our Healthcare Business”
New heading “The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”
New heading “The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”
New heading “The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”
New heading “The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”
New heading “The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”
New heading “The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”
New heading “The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”
New heading “The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”
Largest changes
These circumstances raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.see in full comparisonOurHowever, management has concluded that the conditions that previously raised substantial doubt about the Company’s ability to continue as a going concern have been alleviated. There can be no assurance that the Company’s efforts will be successful in addressing its liquidity needs. The accompanying consolidated financial statements do not include any adjustments thattomight result should theamounts and classification of assets and liabilities that may be necessary should weCompany be unable to continue as a going concern.Our ability to continue as a going concern depends on our ability to raise additional capital as described above to support our future operations.
“The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”see in full comparison
“The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”see in full comparison
“The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”see in full comparison
“The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”see in full comparison
“The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.”see in full comparison
Full comparison: every changed paragraph (65)
On March 19, 2026, we consummated and completed the Merger pursuant to the Merger Agreement, as further described below. The discussion and financial information presented in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.
Following the closing of the Merger, the Company will conduct its operations through two primary business divisions. Our AI cloud computing business specializes in GPU-accelerated infrastructure for AI workloads and our healthcare business consists of our wellness ring (formerly referred to as the Evie Ring) (the “Wellness Ring”), a wearable designed specifically for women that was launched in November 2023.
Recent Developments
On March 19, 2026, Corvex, Inc. (formerly known as Movano Inc.), acquired Corvex Legacy Holdings, Inc. (formerly known as Corvex, Inc.) (“Corvex OpCo”), in accordance with the terms of the Amended and Restated Agreement and Plan of Merger, dated March 19, 2026 (the “Merger Agreement”), by and among the Company, Thor Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”), and Corvex OpCo. Pursuant to the Merger Agreement, Merger Sub merged with and into Corvex OpCo, pursuant to which Corvex OpCo was the surviving corporation and became a wholly owned subsidiary of the Company (the “Merger”). The Merger Agreement amended and restated in its entirety the prior merger agreement between the parties which was entered into and announced on November 6, 2025 (the “Prior Merger Agreement”).
Under the terms of the Merger Agreement, at the closing of the Merger (the “Closing”), the Company issued to the prior securityholders of Corvex OpCo (i) 240.562 shares of Series B Convertible Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”), which such shares of Series B Preferred Stock, on an as-converted basis, represented no more than 19.9% of the outstanding shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock” or the “common stock”) immediately prior to the Closing, (ii) 23,551.5195 shares of Series C Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”) and (iii) 30,227.0524 shares of Series D Non-Voting Convertible Preferred Stock, par value $0.0001 per share (the “Series D Preferred Stock”).
Each share of Series B Preferred Stock will automatically convert into 1,000 shares of Common Stock on March 31, 2026, which is one day following the March 30, 2026 record date of the stock dividend payable to holders of the Company’s Common Stock and Series A Preferred Stock pursuant to the Merger Agreement. Subject to and contingent upon the affirmative vote of a majority of the shares of common stock present or represented and entitled to vote at a meeting of stockholders of Company to approve, for purposes of the Nasdaq Listing Rules, the issuance of shares of Common Stock to the stockholders of Corvex upon conversion, (1) each share of Series C Preferred Stock will automatically convert into 1,000 shares of Common Stock And (2) Each share of Series D Preferred Stock will be convertible into 1,000 shares of Common Stock.
In connection with entry into the Prior Merger Agreement and as described below, (1) the Company raised $3.0 million in equity capital pursuant to the Series A Subscription Agreement, and (2) the Company entered into a $1.0 billion Equity Facility with Chardan Capital Markets LLC.
The descriptions of the Company’s two business divisions, their corresponding products, and business models are summarized below.
AI Cloud Computing Business
Our engineering-led, AI computing platform specializes in GPU-accelerated infrastructure for AI workloads.
Our platform allows organizations to leverage the advantage of AI by providing secure, scalable, and cost-efficient computational resources. Our infrastructure leverages advanced GPU-accelerated compute clusters, high-throughput storage systems and layered architecture to provide enhanced security, consistent performance and efficiency at scale.
We provide a range of capabilities, including:
Our Healthcare Business
Prior to the Merger, on May 15, 2025, Movano Inc. announced that it had initiated a process to explore strategic alternatives to maximize shareholder value. In order to conserve cash, it reduced our operations and turned its primary focus to consummating a strategic transaction with the goal of maximizing shareholder value, which resulted in the Merger described above. While we expect to ultimately dispose of the assets related to our legacy healthcare business, as of the date of this filing we are continuing to operate this business in a reduced capacity as we explore available opportunities.
Our commercial product was the wellness ring (formerly referred to as the Evie Ring) (the “Wellness Ring”), a wearable designed specifically for women that was launched in November 2023. We launched the Wellness Ring as a general wellness device without any FDA premarket clearances. All revenues from the sale of the Wellness Ring were generated in the United States. Following a final order by the Trademark Trial and Appeal Board (“TTAB”) of the United States Patent and Trademark Office sustaining Allora Health, Inc. d/b/a EVVY’s (“EVVY”) opposition to the Company’s registration of its EVIE mark for two of the three classes of products challenged by EVVY and receipt from EVVY of a cease and desist letter relating to our use of the EVIE mark, we currently have paused all commercial sales of the Wellness Ring (See Note 16 Subsequent Events in our consolidated financial statements for further discussions).
Movano Inc., dba Movano Health, a Delaware corporation,
is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of
consumer health devices.
Our initial commercial product is the Evie Ring,
a wearable designed specifically for women that was launched in November 2023. The Evie Ring combines health and wellness metrics to give
a full picture of one’s health, which include resting heart rate, HRV, SpO2, respiration rate, skin temperature variability,
period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep
stages and duration, and mood tracking. The device provides women with continuous health data distilled down to simple, yet meaningful,
insights to help them make manageable lifestyle changes and take a more proactive approach that could mitigate the risks of chronic disease.
We launched the Evie Ring as a general wellness device without any FDA premarket clearances. All revenues from the sale of the Evie Ring
were generated in the United States.
Separately, in November 2024, we received FDA
510(k) clearance for the pulse oximetry feature in our EvieMED Ring, making it a medical device. The clearance enables us to pursue health
solutions needed for applications such as clinical trials, post-clinical trial management, and remote patient spot check monitoring for
both healthcare providers and payors. We believe EvieMED is one of the first patient wearables with FDA clearance on the entire system,
both hardware and software, differing from our competition which sometimes gets FDA clearance on an individual algorithm under “Software
as a Medical Device” guidance. The FDA clearance of these metrics, including pulse rate and SpO2, will be sold via prescription
under the brand name EvieMED, and will help to ensure clinical-level confidence in EvieMED’s monitoring capabilities and make the
device attractive to clinicians and to facilities engaged in clinical trials for at-home and/or long-term patient monitoring. This unique
competitive advantage is not only a key pillar in building brand trust and loyalty but will also redefine the expectations of wearable
devices.
In addition to the Evie Ring and EvieMED Ring,
we are developing one of the smallest patented and proprietary SoC designed specifically for blood pressure or CGM systems. We built the
integrated sensor from the ground up with multiple antennas and a variety of frequencies to achieve an unprecedented level of precision
in health monitoring. We are currently conducting clinical trials with the SoC and developing algorithms that, if successful, will enable
us to develop wearables that can monitor glucose non-invasively and blood pressure without a cuff. Our end goal is to bring a Class II
FDA-cleared device to the market that includes CGM and cuffless blood pressure monitoring capabilities. Over time, our technology could
also enable the measurement and continuous monitoring of other health data.
On April 28, 2021, the Company established Movano
Ireland Limited, organized under the laws of Ireland, as a wholly owned subsidiary of the Company.
The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.
We are a technology company that was
were formed in January 2018. We have
a limited operating history and have generated only limited revenue to-date. We have largely focused
our efforts and resources towards
research and development activities relating to our development of the EvieWellness Ring, EvieMEDMedical Ring
and the SoC, the commercial launch of the
Evie Wellness Ring and the FDA 510(k) clearance for the pulse oximeter feature of the EvieMEDMedical Ring.
To date, we have funded our operations primarily
from the sale of our equity securities.
We
have incurred net losses in each year since
inception. Our losses were $23.7$18.3 million and $29.3$23.7 million for the years ended December 31, 2024
2025 and 2023,2024, respectively.
Substantially all our net losses have resulted from costs incurred in connection with our research and development
programs and from sales,
general and administrative costs associated with our operations.
Reverse
Stock SplitSplits
On
October 29, 2024, wethe Company completed a 1-for-15 reverse
stock split of ourits issued and outstanding common stock. As a result of the
reverse stock split, each share of common stock issued and
outstanding immediately prior to October 29, 2024 was automatically reclassified
and converted into one-fifteenth (1/15th) of a share
of common stock. The reverse stock split affected all common stockholders uniformly and did not alter any stockholder’s percentage
interest in our equity, except to (the extent“2024 thatReverse theStock reverse stock split resulted in a stockholder of record owning a fractional share.
Stockholders of record who were otherwise entitled to receive a fractional share, instead automatically had their fractional shares rounded
up to the next whole share. No cash was issued for fractional shares as part of the reverse stock split.Split”).
On October 10, 2025, the Company completed a 1-for-10 reverse stock split of its issued and outstanding common stock. As a result of the reverse stock split, each share of common stock issued and outstanding immediately prior to October 10, 2025 was automatically reclassified and converted into one-tenth (1/10th) of a share of common stock (the “2025 Reverse Stock Split”, and together with the 2024 Reverse Stock Split, the “Reverse Stock Splits”).
The Reverse Stock Splits affected all common stockholders uniformly and did not alter any stockholder’s percentage interest in the Company’s equity, except to the extent that the reverse stock split resulted in a stockholder of record owning a fractional share. In the 2024 Reverse Stock Split, stockholders of record who were otherwise entitled to receive a fractional share, instead automatically had their fractional shares rounded up to the next whole share. No cash was issued for fractional shares as part of the 2024 Reverse Stock Split. In the 2025 Reverse Stock Split, stockholders of record who were otherwise entitled to receive a fractional share, instead received cash in lieu of such fractional share equal to such fraction multiplied by the average of the closing sales prices of the Company’s common stock on the Nasdaq during regular trading hours for the ten consecutive trading days immediately preceding the effective date of the 2025 Reverse Stock Split (with such average closing sales prices being adjusted to give effect to the reverse stock split).
The
Reverse reverseStock stock splitSplits did not change the par
value of the common stock or the authorized number of shares of common stock. Proportionate
adjustments were made to the exercise prices
and the number of shares underlying ourthe Company’s equity plans and grants thereunder, pursuant to the terms thereof. The amount of undistributed
shares of Common Stock deemed to be covered by our effective registration statements on Forms S-3 and S-8 were proportionately reduced
as of the effective time of the reverse stock split at the Reverse Stock Split Ratio.applicable. Additionally, proportionate adjustments were made
to the exercise prices and the number of shares underlying all outstanding
warrants, as required by the terms of these securities.
All common
share and per-share amounts in thisthese Formconsolidated 10-Kfinancial statements have been
retroactively restated to reflect the effect of
the reverseReverse stockStock split.Splits.
The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.
The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.
Revenue
totaled totaled$0.4 million and $1.0 million and $0 for the
years ended December 31, 20242025 and 2023,2024, respectively. This increasedecrease of $1.0$0.6 million
was due to a reduction in marketing effort, leading to lower sales volume and the corresponding recognition of revenue upon the transfer
transfer of control of the EvieWellness Ring Elements, which began in the first quarter of 2024.
Cost
of revenue totaled $3.0$2.3 million and
$0 $3.0 million for the years ended December 31, 20242025 and 2023,2024, respectively. This increase decrease
of $3.0$0.7 million was primarily due to lower revenue for the year ended December 31, 2025 compared to the year ended December 31,
2024. Cost of revenue for the year ended December 31, 2025 included direct costs of $2.1$0.6 million related to the transfer of
control of the various Wellness Ring Elements, $0.5 million for labor and related stock-based compensation, $0.4 million of
order processing, shipping and fulfillment costs, and $0.8 million for inventory that was designated as scrap materials. Cost of
revenue for the year ended December 31, 2024 included direct costs of $1.7 million related to the transfer of control of the
various EvieWellness Ring Elements, $0.2 million for labor and related stock-based compensation, $0.3 million of order processing,
shipping and fulfillment
costs, and $0.7 million for inventory that was designated as scrap materials.
Research
and development expenses totaled $11.2$5.7 million and $16.9$11.2 million
for the years ended December 31, 20242025 and 2023,2024, respectively.
This decrease of $5.7$5.5 million was due primarily to lower research
and laboratory expenses and other professional fees, partially offset by an increase in employee compensation.fees. Research
and development
expenses for the year ended December 31, 2025 included expenses related to employee compensation of $3.5 million,
other professional fees of $1.6 million, tools and equipment expenses of $0.2 million, rent of $0.1 million, depreciation
and amortization of $0.1 million, and other expenses of $0.2 million. Research and development expenses for the year ended
December 31, 2024 included expenses related to employee compensation of $5.8 million, other professional
fees of $3.3 million,
tools and equipment expenses of $1.4 million, rent of $0.1 million, depreciation and amortization
of $0.1 million, and
other expenses of $0.5 million. Research and development expenses for the year ended December 31,
2023 included expenses related to employee compensation of $5.6 million, other professional fees of $5.7 million, tools and
equipment expenses of $4.4 million, rent of $0.2 million, depreciation and amortization of $0.1 million, and other expenses
of $0.9 million.
Sales,
general and administrative expenses totaled
$11.0 $7.9 million and $12.8$11.0 million for the years ended December 31, 20242025 and 2023, 2024,
respectively. This decrease of $1.8$3.1 million
was due primarily to lower headcount with respect to sales, general and administrative
employees employeesas a result of less activity and decreased marketing costs. Sales,
general and administrative expenses for the year ended December 31,
2025 included expenses related to marketing and other expenses of $1.3 million, employee and board of director compensation of $3.1 million,
professional and consulting fees of $3.4 million, and rent of $0.1 million. Sales, general and administrative expenses for
the year ended December 31, 2024 included expenses related to marketing and other expenses
of $2.1 million, employee and board
of director compensation of $5.7 million, professional and consulting fees of $3.1 million,
and rent of $0.1 million. Sales, general and administrative expenses for the year ended December 31, 2023 included expenses
related to marketing and other expenses of $4.2 million, employee and board of director compensation of $5.9 million, professional
and consulting fees of $2.6 million, and rent of $0.1 million.
Other
income (expense), net for the year ended
December 31, 20242025 was a net other incomeexpense of $0.5$2.8 million as compared to a net other income
of $0.4$0.5 million for the year
ended December 31, 2023.2024. The increaseincreased expense was due primarily to $3.0 million of $0.1interest millionexpense
(related wasparty) primarilyfor duethe toamortization higherof averagethe cashoriginal holdingsissue discount on the bridge loan during the year.year ended December 31, 2025.
The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.
At December 31, 2025, we had cash and cash equivalents of $2.8 million. During the year ended December 31, 2025, we used $11.3 million of cash in our operating activities.
On August 6, 2025, we entered into a Loan Agreement and Promissory Note pursuant to which we obtained $1,500,000 in secured debt financing (the “Bridge Loan”). On November 6, 2025, we entered into a Preferred Stock Subscription Agreement (the “Series A Subscription Agreement”), with the investors party thereto (the “Series A Purchasers”), pursuant to which we sold 3,000 shares of Series A Preferred Stock to the Series A Purchasers for a purchase price per share equal to $1,000 and an aggregate purchase price of $3,000,000. Additionally, on November 6, 2025, we entered into a ChEF purchase agreement (the “ChEF Purchase Agreement”) with Chardan Capital Markets LLC (“Chardan”) related to a “ChEF,” Chardan’s committed equity facility (the “Equity Facility”). Pursuant to the ChEF Purchase Agreement, we have the right from time to time to sell to Chardan up to $1,000,000,000 in aggregate gross purchase price of newly issued shares of our common stock, subject to having an effective Registration Statement on Form S-1 on file with the SEC covering the sales thereunder and other conditions and limitations as set forth in the ChEF Purchase Agreement. Subsequent to year end, on March 19, 2026 the Company completed its acquisition of Corvex OpCo, an AI cloud computing company specializing in GPU-accelerated infrastructure for AI workloads, pursuant to the Merger Agreement. Following the Merger, the Company was renamed Corvex, Inc., effective March 23, 2026.
Our funding requirements are highly dependent on the needs of our AI cloud computing business on a go forward basis. We have incurred significant expenses in connection with our evaluation of strategic alternatives and entry into the Merger Agreement, and we expect to continue to incur expenses in connection with the ongoing process of exploring transactions with certain third parties to monetize certain legacy assets. A considerable portion of these expenses, such as legal, accounting and advisory fees and other related charges, will be incurred regardless of whether we enter into a monetization transaction for our legacy healthcare assets.
Additionally, in connection with our entering into of the Merger Agreement, we entered into an amendment of the Bridge Loan providing for an extension of the maturity date to June 30, 2026 in exchange for our agreeing that upon any sale or other disposition of all or substantially all the Company’s legacy assets, we will be obligated to repay the $1.5 million principal of the Bridge Loan, plus any other outstanding obligations plus a $3.0 million repayment premium and any other proceeds from the sale of such legacy assets. Pursuant to the Bridge Loan, as amended, if the Company has not sold the legacy assets by the maturity date, the Company would transfer such assets to the lender on the maturity date in full satisfaction of the debt.
As a result of the completion of the Merger, including the anticipated operational and financial benefits and access to additional resources, we believe our cash and cash equivalents will be sufficient to fund our operations through the next twelve months. In addition, changing circumstances could cause us to consume capital significantly faster than we currently anticipate, and we may need to spend more than currently expected because of circumstances beyond our control. As a result, we could deplete our capital resources sooner than we currently expect. If we are unable to obtain such needed funds, our financial condition and results of operations may be materially adversely affected, we may not be able to continue operations, and our board of directors may decide that it is in the best interests of our stockholders to commence bankruptcy or liquidation and dissolution proceedings.
At December 31, 2024, we had cash and
cash equivalents of $7.9 million. During the year ended December 31, 2024, we used $22.5 million of cash in our
operating activities. Our cash and cash equivalents are not expected to be sufficient to fund our operations beyond the second
quarter of 2025. We will require additional investment capital or other funding during the second quarter of fiscal 2025 to support
our current business and growth plan. We are currently exploring various possible financing options that may be available
to us, which may include a sale of our securities and/or strategic partnership transactions. We have no commitments to
obtain any additional funds, and there can be no assurance such funds will be available on acceptable terms or at all. If we
are unable to obtain such needed funds, our financial condition and results of operations may be materially adversely affected, and
we may not be able to continue operations.
In August 2022, we entered into an at-the-market
issuance (“ATM”) agreement to sell shares of our common stock for aggregate gross proceeds of up to $50.0 million, from time
to time, through an ATM equity offering program. During the years ended December 31, 2024 and 2023, the Company sold an aggregate
of 305,841 and 168,783 shares of common stock, respectively, through the ATM program for proceeds of approximately
$1.7 million and $3.2 million, net of commissions and other costs of issuance, respectively. Approximately $42.5 million
remains available on the ATM equity offering program at December 31, 2024.
On April 2, 2024, the Company entered into a securities
purchase agreement for the private placement of an aggregate of 3,015,172 units with each unit consisting of (1) one share of the Company’s
common stock or at the election of the purchaser a pre-funded warrant, and (2) one warrant to purchase one share of common stock. The
purchase price paid for each unit was $8.00. Certain directors and officers participated and purchased 19,168 units at an offering
price of $8.48 per unit.
Each pre-funded warrant has an exercise price
of $0.015 per share, was immediately exercisable on the date of issuance and does not expire. Each warrant has an exercise price equal
to $6.11 per share, was exercisable immediately and expires on the fifth anniversary of the initial exercise date of the warrant. The
warrants issued to the Company’s officers and directors have an exercise price equal to $6.60.
The private placement transaction closed on April
5, 2024, resulting in gross proceeds to the Company of approximately $24.1 million, before deducting offering fees and expenses of approximately
$1.5 million.
We expect to continue to incur significant expenses and operating losses
for at least the next several years.
We
expect to continue to incur significant expenses. Until we can generate a sufficient amount of revenue
from our products,operations, if ever,
we expect to finance future cash needs through public or private equity offerings, debt financings or corporate
collaborations and licensing arrangements.collaborations. Additional
funds may not be available when we need them on terms that are acceptable to us,
or at all. If adequate funds are not available, we may
be required to delay, reduce the scope of or eliminate one or more ofrevise our research
oroperational development programs or our commercialization effortsplans or it may become impossible for us to remain in operation. To the extent that
we raise additional
funds by issuing equity securities, our stockholders may experience additional dilution, and debt financing, if available,
may involve
restrictive covenants. To the extent that we raise additional funds through collaborations and licensing arrangements, it
may be necessary to relinquish some rights to our technologies or applications or grant licenses on terms that may not be favorable to
us. We may seek to access the public or private capital markets whenever conditions are favorable, even if we do not
have an immediate
need for additional capital at that time.
These
circumstances raise substantial doubt about
the Company’s ability to continue as a going concern within one year after the date
that the consolidated financial
statements are issued. OurHowever, management has concluded that the conditions that previously raised substantial
doubt about the Company’s ability to continue as a going concern have been alleviated. There can be no assurance that the Company’s
efforts will be successful in addressing its liquidity needs. The accompanying consolidated financial statements do not include any adjustments
that tomight result should the amounts and classification of assets and
liabilities that may be necessary should weCompany be unable to continue as a going concern. Our ability to continue as a going concern depends
on our ability to raise additional capital as described above to support our future operations.
The $11.3 million used in operating activities during the year ended December 31, 2025 was primarily attributable to our net loss of $18.3 million. The net loss was offset by changes in our operating assets and liabilities totaling $0.2 million, and by non-cash items, including stock-based compensation of $2.9 million, amortization of debt discount (related party) of $2.9 million, depreciation and amortization of $0.1 million, interest expense on bridge loan (related party) of $0.1 million, and the write-down of inventory to net realizable value of $0.8 million.
The $26.2 million used in operating activities
during the year ended December 31, 2023 was primarily attributable to our net loss of $29.3 million and changes in our operating
assets and liabilities totaling $0.3 million. These items were offset by non-cash items, including stock-based compensation of $3.0 million,
non-cash lease expense of $0.2 million, and depreciation and amortization of $0.2 million.
During the year ended December 31, 2025 we used no cash in investing activities. During the year ended December 31, 2024 we used cash of $8,000 in investing activities, consisting of purchases of property and equipment.
During the year ended December 31, 2023 we
used cash of $64,000 in investing activities, consisting of purchases of property and equipment.
During
the year ended December 31, 2024,
2025, we were provided cash of $24.3$6.2 million from financing activities, which included net proceeds
of $3.0 million from the sale of $22.6Series A preferred stock, net proceeds of $1.6 million from the issuance of common stock, pre-funded
warrants and common stock warrants,through
the andATM netactivity, proceeds of $1.7$1.5 million forfrom the bridge loan and $0.1 million from the issuance of common stock throughupon the
exercise ATMof activity.stock options.
During
the year ended December 31, 2023,
2024, we were provided cash of $21.6$24.3 million from financing activities, which included net proceeds
of $6.7 million, $8.1 million and $3.6$22.6 million from the issuance
of equitycommon securitiesstock, inpre-funded public offerings in February 2023, June 2023warrants and Novembercommon 2023,stock respectively,warrants, and net proceeds of $3.2$1.7 million
from the issuance of common stock through the ATM equity offering program.activity.
The discussion and financial information presented in this section relate only to the historical operations of the Company prior to the completion of the Merger, which principally reflect our Healthcare Business, and should be read in that context. Accordingly, the historical results presented herein are not inclusive of the financial position, results of operations and cash flows of Corvex OpCo, which principally reflect our AI Cloud Computing Business.
We
anticipate that, excluding non-recurring items,
we will continue to generate annual losses for the foreseeable future as we continue
to theexecute commercializationon and further development of
our Eviebusiness Ring and other products in development.plan. We will require additional capital to fund and grow our operations, to complete our ongoing and
planned clinical studies, to commercialize our products, to
continue investing in and to further develop our general infrastructure, and
such funding may not be available to us on acceptable terms
or at all.
We
expect to satisfy future cash needs through
existing capital balances, through some combination of public or private equity offerings,
debt financings, licensing arrangements, and
other marketing and distributionpartnership arrangements. Please see “Risk Factors—Risks Related to Our Business.Factors.”
What changed in the latest 10-Q
Risk Factors
We operate in a rapidly changing environment that involves a number of risks that could materially affect our business, financial condition or future results, some of which are beyond our control. In addition to the other information set forth in this report, the risks and uncertainties that we believe are most important for you to consider are discussed in Part I, “Item 1A. Risk Factors” in the 2025 Form 10-K and subsequently filed Quarterly Reports on Form 10-Q.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
New heading “Sale of Legacy Assets”
New heading “Other Income (expense)”
Removed heading “Merger with Corvex OpCo”
Removed heading “Interest and Other (Expense) Income, Net”
Largest changes
“On August 3, 2026, Corvex Primus LLC, a subsidiary of the Company, entered into the GPU Loan Agreement with GPU Finance Ltd., a subsidiary of the USD.AI Foundation, as initial lender, and Corvex Primus Holdco LLC, as parent, establishing a secured equipment financing facility to fund the purchase of GPU servers and related infrastructure for the Company’s AI Factory data centers. Corvex OpCo provided a limited guaranty of the borrower’s obligations pursuant to a Limited Guaranty Agreement. …”see in full comparison
As a result of the Merger, including anticipatedsee in full comparisonanticipatedoperational and financial benefits and access to additional resources, we believe our cash and cash equivalents will be sufficient totofund operations for the next twelve months. However, changing circumstances may cause us to consume capital faster than expected. If we are unable to obtain additional funding, our financial condition may be materially adversely affected, and we may not be able to continue operations. In such circumstances, the Board may determine that bankruptcy or liquidation is in the best interests of stockholders.
Full comparison: every changed paragraph (77)
On March 19, 2026, Corvex, Inc. (formerly known
as Movano Inc.) (the “Company”), acquired Corvex Legacy Holdings, Inc. (formerly known as Corvex, Inc.) (“Corvex OpCo”),
in accordance with the terms of the Amended and Restated Agreement and Plan of Merger, dated March 19, 2026 (the “Merger Agreement”),
by and among the Company, Thor Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”),
and Corvex OpCo. Pursuant to the Merger Agreement, Merger Sub merged with and into Corvex OpCo, with Corvex OpCo surviving as a wholly
owned subsidiary of the Company (the “Merger”). The Merger Agreement amended and restated the prior merger agreement entered
into on November 6, 2025. Concurrent with the Merger, the Company changed its name to Corvex, Inc., effective March 23, 2026. As a result
of this transaction, Corvex OpCo became a wholly owned subsidiary of the Company. This transaction representsrepresented a significant change in
the Company’s business and strategy.
Corvex is an AI cloud computing business specializing in GPU-accelerated infrastructure for AI workloads. Our AI cloud computing business is an engineering-led platform focused on providing secure, scalable, and cost-efficient GPU-accelerated infrastructure for AI workloads, supported by GPU-accelerated compute clusters, high-throughput storage systems, and a layered architecture intended to enhance security and deliver consistent performance and efficiency at scale. Our AI cloud computing offerings include AI Factories and GPU Clusters, confidential computing (including our patent-pending Corvex Secure Model Weights product), and Token Factory (currently in development), which is expected to provide access to premium open-source AI models via API integration and a performance-optimized inference engine on automatically scaling infrastructure.
Following the merger, the Company operates through
two business divisions:
Sale of Legacy Assets
As previously disclosed, on August 6, 2025, the Company entered into a Loan Agreement and Promissory Note (as later amended, the “Loan Agreement”) with Evie Holdings, LLC (the “Lender”), pursuant to which the Company obtained $1,500,000 in bridge financing (the “Bridge Loan”). On June 30, 2026, the Company completed the transfer of the legacy healthcare assets to the Lender in full satisfaction of its outstanding debt and obligations under the Bridge Loan.
Merger with Corvex OpCo
On March 19, 2026, the Company acquired Corvex
OpCo in accordance with the Merger Agreement.
Under the terms the Merger Agreement, at the closing
of the Merger (the “Closing”), the Company issued to the prior security holders of Corvex OpCo (i) 240.562 shares of Series
B Convertible Preferred Stock, par value $0.0001 per share (the “Series B Preferred Stock”), which such shares of Series B Preferred
Stock, on an as-converted basis, represented no more than 19.9% of the outstanding shares of the Company’s common stock, par value $0.0001
per share (the “Common Stock”) immediately prior to the Closing, (ii) 23,551.5195 shares of Series C Non-Voting Convertible
Preferred Stock, par value $0.0001 per share (the “Series C Preferred Stock”) and (iii) 30,227.0524 shares of Series D Non-Voting
Convertible Preferred Stock. par value $0.0001 per share (the “Series D Preferred Stock”).
Each share of Series B Preferred Stock was automatically
converted into 1,000 shares of Common Stock on March 31, 2026, which is one day following the March 30, 2026 record date of the stock
dividend, equal to 0.358 shares of Common Stock for each share outstanding to holders of the Company’s Common Stock and Series A
Preferred Stock pursuant to the Merger Agreement, which was ultimately distributed on April 6, 2026 (the “Stock Dividend”).
Subject to and contingent upon the affirmative
vote of a majority of the shares of common stock present or represented and entitled to vote at a meeting of stockholders of Company to
approve, for purposes of the Nasdaq Listing Rules, the issuance of shares of Common Stock to the former equity holders of Corvex OpCo
upon conversion, (1) each share of Series C Preferred Stock will automatically convert into 1,000 shares of Common Stock And (2) each
share of Series D Preferred Stock will be convertible into 1,000 shares of Common Stock.
These transactions were undertaken to support
the Company’s strategic repositioning and expected growth in its AI cloud computing business.
AI Cloud ComputingOur Business
Sale of Legacy Assets
Prior to the closing of the Merger, the Company operated a consumer wearable health technology business centered on the wellness ring (formerly referred to as the Evie Ring) and related connected devices and services (the “Legacy Business”). The Legacy Business represented substantially all of the Company’s historical commercial operations prior to the Merger, including the development and commercialization of the wellness ring, proprietary radio frequency technologies, and related cuffless blood pressure and noninvasive glucose monitoring development programs.
In connection with the Third Amendment to the Loan Agreement and Promissory Note with Evie Holdings, LLC (the “Lender”), dated March 19, 2026 (the “Third Amendment”), the Company agreed to transfer all assets of the Legacy Business to the Lender in full satisfaction of the outstanding obligations under the Loan Agreement, including $1.5 million of principal, accrued and unpaid interest, and a $3.0 million repayment premium (the “Asset Transfer”). The Asset Transfer was consummated on June 30, 2026, and upon consummation, all indebtedness, liabilities, and obligations of the Company under the Loan Documents were deemed satisfied in full and all liens on the Company’s assets were automatically released and terminated.
Management concluded that the disposal of the Legacy Business does not represent a strategic shift that has a major effect on the Company’s operations and financial results.
As a result, the results of operations for the
threesix months ended MarchJune 31,30, 2026 include (i) the Company’s legacy healthcare operations for the full period and (ii) the results of
of Corvex OpCo for the period from March 19, 2026 through MarchJune 31,30, 2026. Accordingly, the results for the current period are not directly
comparable to prior periods.
Revenue associated with our AI Platform and services is generated through fixed-term contracts. AI Platform revenue is derived from these fixed-term contracts, where customers pay a fixed fee for reserved compute and storage capacity across our fleet of servers and contracted support services over the contract term, regardless of the level of utilization.
The Company generates revenue through fixed-term
contracts under which we reserve compute and storage capacity across our fleet of servers and provide related support services. Customers
pay a fixed fee for the reserved capacity and contracted services over the contract term, regardless of utilization. Compute capacity
is delivered across two infrastructure tiers: (1) high-performance GPU servers for intensive AI training and inference workloads, and
(2) virtual machines provisioned on shared CPU servers for general-purpose compute, development, testing, and supporting AI workloads
such as data preprocessing and orchestration. Customers may also contract for integrated storage capacity and platform services, including
managed Kubernetes, confidential computing, and service packages. The Company’s primary performance obligation is to stand ready
to provide access to specified compute capacity, enabling customers to submit and process workloads on GPU and CPU servers. Revenue is recognized on a straight-line basis over the stated customer contract term.
Cost of revenue primarily consists
of direct costs
in operating high-performance computing equipment within leased data centers,center suchspace. asOther costs included in this line are
fees for bandwidth usage via fixed-capacity ISP contract, utilities including power, rent, labor costs and network access. The Company
operates data centers
and has co-location service agreements. These agreements generally commit the Company to pay monthly fees plus additional
fees for bandwidth
usage above the committed level.
CostsCost of revenue consists primarily
of material costs, freight charges,
purchasing and receiving costs, inspection costs, customer support, data hosting services and other
costs, which are directly attributable
to the production of the Company’s product. Write-down of inventory to lower of cost or net
realizable value is also recorded in
cost of revenue.
Technology
and infrastructure expense consists of costs associated with our infrastructure, such as personnel costs for employees associated
with with
research and development of new and existing products and services or with maintaining our computing infrastructure,
such as salaries
and benefits, bonuses, benefits, stock-based compensation expense, lab supplies and facility costs, travel
expenses, fees paid to non
employeesnon-employees conducting certain research activities and other related expenses, and costs related to
software subscriptions. The Company’s
technology and infrastructure efforts are dedicated towards developing new services,
improving the Company’s existing infrastructure,
adding new features, bringing the latest compute technology to market and
improving the accessibility of the Company’s services.
Other (expense)
income, net
relates primarily to interest income earned cash balances held in interest bearing bank accounts and interestthe expensegain relatedon disposal of assets represents
the excess amount of carrying value of the Bridge Loan over the assets transferred to leases.settle the Bridge Loan.
Three and six months ended
June March 31,30, 2026 and 2025
Our condensed consolidated
statements of operations
for the three and six months ended MarchJune 31,30, 2026 and 2025, as discussed herein are presented below.
Revenue totaled $510$3.8 million and $103 thousand and $206 thousand
for the three months
ended MarchJune 31,30, 2026 and 2025, respectively. Revenue inFor the currentthree periodmonths ended, revenue increased $3.7 million, primarily due to the acquisition
of Corvex OpCo which reported $475$3.8 thousandmillion in revenue. This was offset by a decrease of $171$103 thousand inassociated revenue from connected devices
caused mostly by a decrease in marketing efforts ofwith the productwind causeddown byof
the ourLegacy strategic shift toward our AI cloud computing business.Business.
For the six months ended June 30, 2026 and 2025, revenue totaled $4.3 million and $309 thousand, respectively. For the six months ended, revenue increased $4.0 million primarily due to the acquisition of Corvex OpCo which reported $4.3 million in revenue. This was offset by a decrease of $274 thousand associated with the wind down of the Legacy Business.
Cost of revenue totaled $512$2.1 thousandmillion and $642
$362 thousand for the three
months ended MarchJune 31,30, 2026 and 2025, respectively. TheFor reductionthe three months ended, the increase is primarily due to the decreaseacquisition of $377 thousand
from the downsizing of our legacy operations and our strategic shift toward our AI cloud computing business. This was offset by the acquisition
of Corvex OpCo and the $247$2.1 thousandmillion in cost of revenue related to AI platform and services. This was offset by the downsizing of the Legacy Business.
Cost of revenue in the current period primarily
relates to direct costs associated with the operation of Corvex’s high-performance
computing equipment within leased data center infrastructure,space, includingwhich includes costs such as rent, network access, utilities
and power expenses,expenses whileand
personnel costcosts, including stock-based compensation, Cost of revenue in the prior-year period reflects operations of the Company’sLegacy legacy healthcare operations.Business.
For the six months ended June 30, 2026 and 2025, cost of revenue totaled $2.6 million and $1.0 million, respectively. For the six months ended, the increase is primarily due to the acquisition of Corvex OpCo and the $2.4 million in cost of revenue related to AI platform services. This was offset by the downsizing of the Legacy Business.
Depreciation and amortization totaled $326$2.7 thousand
million and $38 thousand$0 for the three
months ended MarchJune 31,30, 2026 and 2025, respectively. TheFor the three months ended, the increase is due primarily to the acquisition of
Corvex OpCo, which reported $295$2.7 thousandmillion in depreciation and amortization. Depreciation and amortization expense in the prior-year period
reflects operations of the Company’sLegacy legacy healthcare operations.Business.
For the six months ended June 30, 2026 and 2025, depreciation and amortization totaled $3.0 million and $0, respectively. For the six months ended, the increase is due primarily to the acquisition of Corvex OpCo, which reported $3.0 million in depreciation and amortization. Depreciation and amortization expense in the prior-year period reflects operations of the Legacy Business.
Technology and infrastructure expense totaled $1.4 million and $1.4 million for the three months ended June 30, 2026 and 2025, respectively.
Technology and infrastructure expense totaled
$822 thousand and $2.4 million forFor the threesix months ended MarchJune 31,30, 2026 and 2025, respectively.technology Technologyand
infrastructure expense totaled $2.2 million and infrastructure$3.8 expense
inmillion, respectively. For the currentsix periodmonths primarily relates to costs associated withended, the Corvex Opco business, including personnel costs for employees engaged
in research and development activities, depreciation associated with servers and software, stock-based compensation expense and other
infrastructure-related costs. It also consists of any current period research and development expense from the Company’s historical
healthcare operations. The decreasechange is primarily due to a $1.7
$2.9 million decrease in research and development expense related to the Company’s
legacyLegacy healthcare operationsBusiness caused primarily dueby a reduction in headcount
as the Company shifted to focus on the AI cloud computing
business, leading to lower personnel and consulting expense in the current period.
The decrease was offset by additional technology and
infrastructure cost of $169$1.3 thousandmillion from the acquisition of Corvex OpCo.OpCo primarily
consisting of personnel costs, including stock-based compensation. Technology and infrastructure expense in the prior-year period reflects
reflectsoperations of the Company’sLegacy legacy healthcare operations ,Business, mainly related to research and development expenses.
Sales and marketing expense totaled $740 thousand and $0 for the three months ended June 30, 2026 and 2025, respectively, and $1.0 million and $0 for the six months ended June 30, 2026 and 2025, respectively. The increase is primarily due to personnel costs of the AI cloud computing business, online advertising spend and events and conferences.
Sales and marketing expense totaled $304 thousand
and $763 thousand for the three months ended March 31, 2026 and 2025, respectively. The decrease is primarily due to the decrease in marketing
efforts for the Company’s legacy healthcare operations due to the shift to the AI cloud computing business. This decrease was offset
by the acquisition of Corvex OpCo which reported $103 thousand in sales and marketing expense. Sales and marketing consists
of personnel costs associated with selling and marketing the Company’s Corvex Cloud Platform, such as salaries, stock-based compensation
expense, commissions, bonuses, and other related expenses, third-party professional services costs, and advertising costs associated with
marketing programs. Sales and marketing expense in the prior-year period reflects the Company’s legacy healthcare operations.
General and administrative expense
totaled $3.4$12.1 million and $1.6 million
for the three months ended MarchJune 31,30, 2026 and 2025, respectively, and $15.5 million and $4.0
million for the six months ended June 30, 2026 and 2025, respectively. The increase is due primarily to increased stock-based compensation
expense related to the replacement awards associated with the acquisition of Corvex OpCo, legal and consulting expenses
due to the merger, increased stock-based compensation expense, Merger,
offset by the reduction in other personnel cost from reduced headcount.
In addition, the increase is also explained by the impact of the
acquisition of Corvex OpCo which added $1.3$11.2 million and $12.5 million for the three and six months ended June 30, 2026 in general
and administrative
expenses. General and administrative expense in the current period primarily consists of personnel-related costs, stock-based
compensation compensation
expense, professional services and lease and other corporate overhead costs.
Loss from operations was $4.8 $15.2
million forand the
three months ended March 31, 2026, as compared to $5.2$3.3 million for the three months ended MarchJune 31,30, 2025.2026 and 2025, respectively, and $20.1 million and $8.5 million for
the six months ended June 30, 2026 and 2025, respectively. The increase was driven by stock-based compensation and a full quarter
of operations related to Corvex OpCo.
Other Income (expense)
Interest and Other (Expense) Income, Net
Other income (expense), net totaled $(158)$2.5 thousand
million and $60$35 thousand for
the three months ended MarchJune 31,30, 2026 and 2025, respectively, and $2.3 million and $95 thousand for the six months ended June 30,
2026 and 2025, respectively. Other income (expense), net in the current period primarily
relates to accruedthe interestgain expenseon anddisposal amortizationof assets related
to the Connected devices business which represents the excess amount of carrying value of the Company’sBridge Loan over the assets transferred
to settle the Bridge Loan, offset, in part, by interest income earned on
cash balances held in interest-bearing accounts.Loan. Other income (expense), net in the prior-year period reflects operations of the Company’sLegacy legacy
healthcare operationsBusiness and also primarily
related to interest and other income.
Net loss was $12.8 million and $3.2 million for the three months ended June 30, 2026 and 2025, respectively, and $17.8 million and $8.4 million for the six months ended June 30, 2026 and 2025, respectively. The increase was driven by stock-based compensation and a full quarter of operations related to Corvex OpCo.
Net loss was $5.0 million for the three months
ended March 31, 2026, as compared to $5.2 million for the three months ended March 31, 2025.
This non-GAAP financial measure
is presented for
supplemental informational purposes only, should not be considered a substitute for financial information presented in
accordance with
GAAP, and may be different from similarly titled non-GAAP measure used by other companies. Other companies, including
companies in our
industry, may calculate this non-GAAP measure differently or may use other measures to evaluate their performance, any
of which could
reduce the usefulness of our disclosure of non-GAAP measure as a tool for comparison. A reconciliation is provided below
for the non-GAAP
financial measure to the most directly comparable financial measure presented in accordance with GAAP. Investors should
review the related
GAAP financial measures and the reconciliation of this non-GAAP financial measure to its most directly comparable GAAP
financial measures,
as well as our financial statements and related notes included elsewhere in this prospectus.Quarterly Report.
We report our financial
results in accordance
with GAAP, however, management believes evaluation of operating results may be enhanced by a presentation of
adjusted EBITDA which is
a non-GAAP financial measure. We define adjusted EBITDA as net loss, excluding (i) depreciation and
amortization, (ii) stock-based compensation,
(iii) benefit from income taxes (iv) transaction costs related to the merger, (iv) Other expense (income)Merger, (v)
gain benefiton fromdisposal incomeof taxes.assets and (vi) interest and other income, net.
(1) See the “Non-GAAP Financial Measures” section included above for a reconciliation to the most directly comparable GAAP measure.
Note: Adjusted EBITDA
for the chief operating decision maker’s
(“CODM”) analysis excludes (i) depreciation and amortization, (ii)
stock-based compensation, (iii) benefit from income taxes, (iv) transaction costs related
to the merger,Merger, (ivv) gain on disposal of assets and (vi) interest and (v)other benefitincome, from income taxes.nets.
Net loss for the AI Platform
and services segment
was $(1,625)$13.9 thousandmillion for the three months ended March 31, 2026, as compared toand $0 for the three months ended MarchJune 31,30, 2025.2026 and 2025, respectively, and $15.5 million
and $0 for the six months ended June 30, 2026 and 2025, respectively.
Adjusted EBITDA loss for the
AI Platform and services
segment was $(98)$2.3 thousandmillion for the three months ended March 31, 2026, as compared toand $0 for the three months ended MarchJune 31,30, 2025.2026 and 2025, respectively, and $2.4
million and $0 for the six months ended June 30, 2026 and 2025, respectively.
The decrease in adjusted EBITDA loss
is due to the inclusion of results
from the AI Platform and services business following the mergerMerger with Corvex OpCo, which did not exist
in the prior-year period, and reflects
the early stage of commercialization, including investments in infrastructure and personnel.
Net income (loss) for the connected
devices and services segment was $1.2 million and $(3,3803.2)
thousand million for the three months ended MarchJune 31,30, 2026,2026 asand compared2025, torespectively,
and $(5,1782.2) thousandmillion and $(8.4) million for the threesix months ended MarchJune 31,30, 2025.2026 and 2025, respectively.
Adjusted EBITDA loss for the connected
devices and
services segment was $(1,506)$0.9 thousandmillion and $2.5 million for the three months ended MarchJune 31,30, 2026,2026 asand compared2025, torespectively,
and $(4,901)$2.4 thousandmillion and $7.4 million for the threesix months
ended MarchJune 31,30, 2025.2026 and 2025, respectively.
The increase in adjusted EBITDA of $3,395$1.6 thousandmillion and $5.0 million for
the three and six months ended is primarily due to reduced operating expenses as the Company downsized its legacyLegacy healthcare operations,Business, partially
offset by stock-based
compensation and transaction-related costs in the current period.
On March 19, 2026, we completed
the acquisition
of Corvex OpCo and determined that the Company is the accounting acquirer. Accordingly, periods prior to the acquisition
reflect the historical
financial statements of the Company, and the results of Corvex OpCo are included beginning on the acquisition date.
As a result, the liquidity
and capital resources information for the three and six months ended MarchJune 31,30, 2026 is not directly comparable
to the prior-year period.
We have incurred significant
operating losses
and negative cash flows from operations since inception and had an accumulated deficit of approximately $171.4$184.2 million
as of MarchJune 31,
30, 2026. We expect to continue to incur net losses for the foreseeable future as we continue to invest in the development
and expansion of
our AI cloud computing business and maintain our legacy healthcare operations in a reduced capacity.business.
As of MarchJune 31,30, 2026, we
had cash and cash equivalents
of approximately $29.3$21.7 million. Based on our current operating plan, we believe that our existing cash and
cash equivalents will be sufficient
to fund our projected operating requirements for at least the next twelve months from the date of
issuance of the condensed consolidated
financial statements.
As of MarchJune 31,30, 2026, we had cash and cash equivalents
of $29.3 $21.7
million. During the six month period ended MarchJune 31,30, 2026, we used $4.3$9.6 million of cash in operating activities.
On August 3, 2026, Corvex Primus LLC, a subsidiary of the Company, entered into the GPU Loan Agreement with GPU Finance Ltd., a subsidiary of the USD.AI Foundation, as initial lender, and Corvex Primus Holdco LLC, as parent, establishing a secured equipment financing facility to fund the purchase of GPU servers and related infrastructure for the Company’s AI Factory data centers. Corvex OpCo provided a limited guaranty of the borrower’s obligations pursuant to a Limited Guaranty Agreement. Under the initial draw (Series A), funded on August 3, 2026 and secured by GPU servers and related equipment, the Company borrowed $7,500,000 in principal, bearing interest at 10.0% per annum (15.0% upon default), amortizing on a mortgage-style basis over a three-year term maturing September 1, 2029. The Company funded a Required Reserve Deposit of $724,565.50 (stepping down over the term absent a continuing event of default) and paid an upfront fee of $150,000. The GPU Loan Agreement permits the Company to request additional Series in the future, subject to the lender’s consent and satisfaction of specified conditions, with all Series cross-collateralized.
Our funding requirements are
highly dependent
on the needs of our AI cloud computing business going forward. We have incurred significant expenses related to evaluating
strategic alternatives
and entering into the Merger Agreement, and we expect to continue incurring expenses related to exploring transactions to monetize certain
legacy assets.Agreement.
In connection with the Merger Agreement, we amended the Bridge Loan to extend the maturity date to June 30, 2026. As part of this amendment, upon any sale or disposition of substantially all legacy assets, we are required to repay the $1.5 million principal, plus outstanding obligations, a $3.0 million repayment premium, and any additional proceeds from such sale. If the legacy assets are not sold by the maturity date, they will be transferred to the lender in full satisfaction of the debt. On June 30, 2026, the Company completed the transfer of the legacy healthcare assets to the Lender in full satisfaction of its outstanding debt and obligations under the Bridge Loan.
As a result of the Merger, including
anticipated anticipated
operational and financial benefits and access to additional resources, we believe our cash and cash equivalents will be sufficient
to to
fund operations for the next twelve months. However, changing circumstances may cause us to consume capital faster than expected. If
we are unable to obtain additional funding, our financial condition may be materially adversely affected, and we may not be able to continue
operations. In such circumstances, the Board may determine that bankruptcy or liquidation is in the best interests of stockholders.
MOVE insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
| Trade date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Demsey Seth |
Conversion | 5,484,388 | — | — |
| 2026-07-07 | Demsey Seth |
Conversion | 31,270 | — | — |
| 2026-07-07 | Crystal John Adler Iii |
Conversion | 708,154 | — | — |
| 2026-07-07 | Crystal John Adler Iii |
Conversion | 3,345,523 | — | — |
| 2026-07-07 | Fairbairn Emily |
Conversion | 1,205,282 | — | — |
| 2026-07-01 | Fairbairn Emily |
Grant/award | 135,800 | — | — |
| 2026-07-01 | Moreland Christopher |
Grant/award | 523,211 | — | — |
| 2026-07-01 | Fleury Patrick |
Grant/award | 100,000 | — | — |
| 2026-07-01 | Donofrio Nicholas M |
Grant/award | 50,000 | — | — |
| 2026-07-01 | Cullinan Brian |
Grant/award | 50,000 | — | — |
| 2026-06-30 | Cullinan Brian |
Option exercise | 48,209 | $0.92 | $44.4K |
| 2026-06-25 | Caballero Ruben |
Option exercise | 29,197 | $0.92 | $26.9K |
Well-known investors holding MOVE (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 15,647 | $339.6K | 0.0% | New position |